title: [Takayasu's arteritis in pregnancy: report seven cases].
abstract: Takayasu's arteritis is a chronic and non-specific disease of young women in reproductive age that primarily affects the aorta, its branches and the pulmonary artery. Ramirez Cueto G. and Fernandez Del Castillo C. et al. published a case of pregnancy in Mexico and Takayasu's arteritis in 1968. There are no reports of this disease in pregnancy since. The purpose of this study is to describe the clinical course and perinatal outcome of seven pregnant patients with known diagnosis of Takayasu arteritis. The clinical course, laboratory findings, angiographic findings and perinatal outcomes were assessed in retrospect in seven pregnant patients with diagnosis of Takayasu's arteritis seen at the National Institute of Perinatology Isidro Espinosa Reyes (Mexico) during the period 2002-2010. The results of the conducted follow-up of 7 patients pregnant with Takayasu's arteritis were: 3 patients were complicated with pre-eclampsia and 2 newborn presented intrauterine growth restriction. Disease activity wasn't observed during pregnancy. No cases of congestive heart failure, brain ischemia or maternal deaths were presented. There were no fetal deaths. We didn't observed induced activity during pregnancy in the cases presented. The most common mother complication was type renovascular hypertension with added severe preeclampsia, which determined the presence of intrauterine growth restriction. There were no maternal or perinatal deaths.
authors.affiliation: Unidad de Terapia Intensiva Adultos, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, México, DF. antonhernanp@yahoo.com
authors.forename: José Antonio
authors.initials: JA
authors.lastname: Hernández-Pacheco
authors.forename: Ariel
authors.initials: A
authors.lastname: Estrada-Altamirano
authors.forename: Arlen
authors.initials: A
authors.lastname: Valenzuela-Jirón
authors.forename: José Luis
authors.initials: JL
authors.lastname: Maya-Quiñones
authors.forename: Javier Andrés
authors.initials: JA
authors.lastname: Carvajal-Valencia
authors.forename: Armando Rogerio
authors.initials: AR
authors.lastname: Chacón-Solís
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002585:Cesarean Section; D005260:Female; D005317:Fetal Growth Retardation / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D006978:Hypertension, Renovascular / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D007231:Infant, Newborn; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008800:Mexico / Q000453:epidemiology; D009543:Nifedipine / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000453:epidemiology / Q000601:surgery; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000453:epidemiology*; D011256:Pregnancy Outcome; D011859:Radiography; D013625:Takayasu Arteritis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000453:epidemiology*; D055815:Young Adult
chemical_list: D000959:Antihypertensive Agents; D008750:Methyldopa; D009543:Nifedipine; D011241:Prednisone